Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia

Leukemia

Volumn 23, Issue 7, 2009, Pages 1342-1343

  Yánez, Lucresia ^a   Bermudez A ^a   Richard, C ^a   Bureo, E ^a   Iriondo, A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ACICLOVIR; ANTIFUNGAL AGENT; ASPARAGINASE; BUSULFAN; CD19 ANTIGEN; CD20 ANTIGEN; CD7 ANTIGEN; CEFUROXIME; CLOFARABINE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBIOTIC PROPHYLAXIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LEUKEMIA; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CHILD; CHILDHOOD LEUKEMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FEBRILE NEUTROPENIA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPE; LETTER; LEUKOCYTE COUNT; LOW DRUG DOSE; MAINTENANCE THERAPY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; THROMBOCYTE COUNT;

EID: 67650930106     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.58     Document Type: Letter

References (9)

1. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004; 15: 1535-1548.
2. Issa JP. DNA methylation as a therapeutic target in cancer. Clin Cancer Res 2007; 6: 1634-1637.
3. Gaynon PS, Harris RE, Altman AJ, Bostrom BC, Breneman JC, Hawks R et al. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. J Clin Oncol 2006; 24: 3150-3156.
4. Chessells JM, Veys P, Kempski H, Henley P, Leiper A, Webb D et al. Long-term follow-up of relapsed childhood acute lymphoblastic leukemia. Br J Haematol 2003; 123: 396-405.
5. Garcia-Manero G, Jeha S, Daniel J, Williamson J, Albitar M, Kantarjian HM et al. Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia. Cancer 2003; 3: 695-702.
6. Hoshino K, Quintás-Cardama A, Yang H, Sanchez-Gonzalez B, Garcia-Manero G. Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia. Leukemia 2007; 5: 906-911.
7. Román-Gómez J, Cordeu L, Agirre X, Jiménez-Velasco A, San José-Eneriz E, Garate L et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 2007; 8: 3462-3469.
8. Roman-Gomez J, Jimenez-Velasco A, Barrios M, Prosper F, Heiniger A, Torres A et al. Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes. Leuk Lymphoma 2007; 7: 1269-1282.
9. Kuang SQ, Tong WG, Yang H, Lin W, Lee MK, Fang ZH et al. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia 2008; 8: 1529-1538.